Our Blog

In our clinical roles at PANTHERx® Rare, we spend a lot of time thinking about two things: How do we help patients access therapy—and how do we better understand their experience once they do? Because too often, what happens between those two moments is where patients get stuck.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! Part 5 of our 6 part series!

By Robert Fetty, Account Manager, PANTHERx Rare Earlier this spring, I attended the Wilson Disease Association for its 2026 Spring Support Symposium in Ann Arbor, Michigan....

Austin Russian discusses the advantages and challenges of manufacturers taking a more active role in the patient journey, as well as how rare disease and cell and gene therapy launches are evolving.

Live from Asembia AXS26, Austin Russian explains how access to rare disease treatments can be delayed.

Every day, our work is guided by one question: how do we help people with rare diseases get the treatments they need so they can focus on living their lives, not navigating systems?

Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs. For 2025, DCI has identified more...

PANTHERx Rare’s CEO, Bansi Nagji, authored an insightful guest post for Drug Channels Institute titled, “The Rare Journey Needs a Special Pharmacy Partner.” He makes...

I recently had the privilege to serve as a Co-Chair of this year’s Access USA Rare Disease Summit, which means I had the privilege of...

Next week, the Drug Channels Institute (DCI) will release our 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. This 17th edition provides our most...